Maravai LifeSciences
MRVI
MRVI
201 hedge funds and large institutions have $3.34B invested in Maravai LifeSciences in 2022 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 71 increasing their positions, 73 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $3.72B → $3.34B (-$383M)
28% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 46
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
201
Holding in Top 10
1
Calls
$10.9M
Puts
$1.73M
Top Buyers
| 1 | +$65.4M | |
| 2 | +$43.1M | |
| 3 | +$43.1M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$39.3M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$38.3M |
Top Sellers
| 1 | -$68.8M | |
| 2 | -$68M | |
| 3 | -$39.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$37.8M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$31.3M |